global pharmaceuticals (uk) limitedEstimated Valuation
£122.7k
Pomanda estimates the enterprise value of GLOBAL PHARMACEUTICALS (UK) LIMITED at £122.7k based on a Turnover of £353.4k and 0.35x industry multiple (adjusted for size and gross margin).
global pharmaceuticals (uk) limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of GLOBAL PHARMACEUTICALS (UK) LIMITED at £0 based on an EBITDA of £0 and a 3.51x industry multiple (adjusted for size and gross margin).
global pharmaceuticals (uk) limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of GLOBAL PHARMACEUTICALS (UK) LIMITED at £0 based on Net Assets of £-462.6k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Global Pharmaceuticals (uk) LimitedOverview
Global Pharmaceuticals (uk) Limited is a live company located in surrey, KT4 7PL with a Companies House number of 02342175. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in February 1989, it's largest shareholder is
second cb trustees ltd
with a 50% stake. Global Pharmaceuticals (uk) Limited is a mature,
micro sized company, Pomanda has estimated its turnover at
£353.4k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Global Pharmaceuticals (Uk) Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating0.5out of 5
0 Strong
1 Regular
4 Weak
Size
annual sales of £353.4k, make it smaller than the average company (£24.4m)
£353.4k - Global Pharmaceuticals (uk) Limited
£24.4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Production
with a gross margin of 16.6%, this company has a higher cost of product (29.5%)
16.6% - Global Pharmaceuticals (uk) Limited
29.5% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
1 - Global Pharmaceuticals (uk) Limited
36 - Industry AVG
Pay Structure
on an average salary of £81.2k, the company has an equivalent pay structure (£81.2k)
£81.2k - Global Pharmaceuticals (uk) Limited
£81.2k - Industry AVG
Efficiency
resulting in sales per employee of £353.4k, this is less efficient (£656k)
£353.4k - Global Pharmaceuticals (uk) Limited
£656k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Global Pharmaceuticals (uk) Limited
- - Industry AVG
GLOBAL PHARMACEUTICALS (UK) LIMITED financials
EXPORT
Global Pharmaceuticals (Uk) Limited's latest turnover from December 2023 is estimated at £353.4 thousand and the company has net assets of -£462.6 thousand. According to their latest financial statements, Global Pharmaceuticals (Uk) Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2009
Turnover
353,439
311,070
301,796
253
Other Income Or Grants
Cost Of Sales
294,865
263,182
253,939
214
Gross Profit
58,574
47,888
47,856
39
Admin Expenses
58,574
47,888
47,856
462,642
702,071
Operating Profit
-462,603
-702,071
Interest Payable
Interest Receivable
125
Pre-Tax Profit
-462,603
-701,946
Tax
Profit After Tax
-462,603
-701,946
Dividends Paid
Retained Profit
-462,603
-701,946
Employee Costs
81,170
78,416
73,401
66,014
Number Of Employees
1
1
1
1
EBITDA*
-462,603
-701,357
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2009
Tangible Assets
4,434
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
4,434
Stock & work in progress
14,330
Trade Debtors
55
43,162
Group Debtors
Misc Debtors
Cash
49,970
misc current assets
total current assets
55
107,462
total assets
55
111,896
Bank overdraft
Bank loan
Trade Creditors
111,572
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
111,572
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
462,603
462,603
462,603
462,603
462,658
702,268
provisions
total long term liabilities
462,603
462,603
462,603
462,603
462,658
702,268
total liabilities
462,603
462,603
462,603
462,603
462,658
813,840
net assets
-462,603
-462,603
-462,603
-462,603
-462,603
-701,944
total shareholders funds
-462,603
-462,603
-462,603
-462,603
-462,603
-701,944
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2009
Operating Activities
Operating Profit
-462,603
-702,071
Depreciation
714
Amortisation
Tax
Stock
14,330
Debtors
-55
55
43,162
Creditors
111,572
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
55
-462,658
-647,277
Investing Activities
capital expenditure
-5,148
Change in Investments
cash flow from investments
-5,148
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
-55
462,658
702,268
share issue
2
interest
125
cash flow from financing
-55
462,658
702,395
cash and cash equivalents
cash
49,970
overdraft
change in cash
49,970
global pharmaceuticals (uk) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for global pharmaceuticals (uk) limited. Get real-time insights into global pharmaceuticals (uk) limited's credit score, group structure and payment trends.
Global Pharmaceuticals (uk) Limited Competitor Analysis
Perform a competitor analysis for global pharmaceuticals (uk) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in KT4 area or any other competitors across 12 key performance metrics.
global pharmaceuticals (uk) limited Ownership
GLOBAL PHARMACEUTICALS (UK) LIMITED group structure
Global Pharmaceuticals (Uk) Limited has no subsidiary companies.
4 the denningtons royal avenue, worcester park, surrey, KT4 7PL
Bank
-
Legal Advisor
-
global pharmaceuticals (uk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to global pharmaceuticals (uk) limited. Currently there are 1 open charges and 0 have been satisfied in the past.
global pharmaceuticals (uk) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLOBAL PHARMACEUTICALS (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
global pharmaceuticals (uk) limitedCompanies House Filings - See Documents
